Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters
- 1 May 1996
- journal article
- Published by Elsevier BV in Nuclear Medicine and Biology
- Vol. 23 (4), 467-471
- https://doi.org/10.1016/0969-8051(96)00023-6
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Regulation of DOPA Decarboxylase Activity in Brain of Living RatJournal of Neurochemistry, 1995
- Time‐course of modifications elicited by reserpine on the density and mRNA synthesis of the vesicular monoamine transporter, and on the density of the membrane dopamine uptake complexSynapse, 1995
- L‐Dihydroxyphenylalanine and its decarboxylase: New ideas on their neuroregulatory rolesMovement Disorders, 1995
- Characterization of [11C]tetrabenazine as an in vivo radioligand for the vesicular monoamine transporterNuclear Medicine and Biology, 1994
- In vivo imaging of monoaminergic nerve terminals in normal and MPTP‐lesioned primate brain using positron emission tomography (PET) and [11C]tetrabenazineSynapse, 1993
- In Vivo Imaging of Vesicular Monoamine Transporters in Human Brain Using [11C]Tetrabenazine and Positron Emission TomographyJournal of Neurochemistry, 1993
- Storage and release of neurotransmittersCell, 1993
- In vivo binding of [11C]tetrabenazine to vesicular monoamine transporters in mouse brainLife Sciences, 1992
- Striatal dopamine deficiency in parkinson's disease: Role of agingAnnals of Neurology, 1989
- Recognition Sites for Norepinephrine Uptake: Regulation by NeurotransmitterScience, 1983